Amedeo Smart

Free Medical Literature Service

 

Amedeo

Arrhythmias
  Free Subscription

Articles published in
Ann Intern Med
    August 2026
  1. YANG Y, Shen CY, Cheng MC, Kang W, et al
    Real-World Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Mitral Stenosis : A Target Trial Emulation.
    Ann Intern Med. 2026 Aug 11. doi: 10.7326/ANNALS-25-04740.
    >> Share

    July 2026
  2. RACO M, Raco D
    In AF at risk for stroke and bleeding, LAAC was not noninferior to medical therapy for a composite of thromboembolic and safety events.
    Ann Intern Med. 2026 Jul 7. doi: 10.7326/ANNALS-26-02439.
    >> Share

  3. RACO M, Raco D
    In AF, LAAC was noninferior to NOAC therapy for a composite efficacy outcome and reduced non-procedure-related bleeding at 3 y.
    Ann Intern Med. 2026;179:JC78.
    >> Share

    May 2026
  4. LIP GYH
    In cardiology outpatients at high stroke risk, smartwatch-based screening vs. usual care increased detection of new onset AF at 180 d.
    Ann Intern Med. 2026 May 5. doi: 10.7326/ANNALS-26-01144.
    >> Share

  5. ATALLA M, Gupta V, Khalid M, Kussmaul WG, et al
    Cardiology: What You May Have Missed in 2025.
    Ann Intern Med. 2026;179.
    >> Share

    April 2026
  6. CRUZ-CUEVAS JD, Wee CC
    Annals Guide to Journal Club - Comparative Effectiveness and Safety of Apixaban, Rivaroxaban, and Warfarin in Patients With Cirrhosis and Atrial Fibrillation.
    Ann Intern Med. 2026 Apr 28:e2601138AG. doi: 10.7326/ANNALS-26-01138.
    >> Share

    March 2026
  7. AGARWAL A, Ezekowitz J
    After cardioversion in AF, continued caffeinated coffee consumption vs. abstinence reduced AF or atrial flutter recurrence at 6 mo.
    Ann Intern Med. 2026 Mar 3. doi: 10.7326/ANNALS-26-00131.
    >> Share

  8. DODD TS, Borzak S
    After successful catheter ablation for AF, rivaroxaban did not reduce a composite of stroke or systemic embolism vs. aspirin at 36 mo.
    Ann Intern Med. 2026 Mar 3. doi: 10.7326/ANNALS-25-05629.
    >> Share

    February 2026
  9. DAWWAS GK, Lewis JD, Tedla YG, Cuker A, et al
    The Risk for Bleeding in Patients With Atrial Fibrillation From Concomitant Use of Apixaban or Rivaroxaban With Diltiazem Compared With Metoprolol.
    Ann Intern Med. 2026 Feb 24. doi: 10.7326/ANNALS-25-01408.
    >> Share

  10. MUKHERJEE D
    In AF with drug-eluting stent for >/=1 y, NOACs were noninferior to NOAC + clopidogrel for a composite of adverse clinical events at 1 y.
    Ann Intern Med. 2026 Feb 3. doi: 10.7326/ANNALS-25-05478.
    >> Share

  11. SHARMA M, Srivastava A
    In patients with ischemic stroke, NVAF, and ASCVD, adding an antiplatelet to OAC therapy did not affect net clinical benefit at 2 y.
    Ann Intern Med. 2026 Feb 3. doi: 10.7326/ANNALS-25-05308.
    >> Share

    January 2026
  12. RUZIEH M
    In adults at high risk for ventricular arrhythmia, treatment to increase potassium to high-normal levels improved a composite outcome.
    Ann Intern Med. 2026 Jan 6. doi: 10.7326/ANNALS-25-04843.
    >> Share

  13. PAPAKONSTANTINOU PE, Lip GYH
    In symptomatic AF, nurse-led pre-ablation lifestyle treatment reduced repeat ablations or cardioversions at 1 y.
    Ann Intern Med. 2026;179:JC6.
    >> Share

  14. WEITZ HH, Merli GJ, Lip G, Frisch D, et al
    Web Exclusive. Annals Consult Guys - Recurrent Atrial Fibrillation: The "Why?" and "When?" of "What to Do?".
    Ann Intern Med. 2026;179:e2600134CG.
    >> Share

    November 2025
  15. RUZIEH M
    In patients with AF and obesity, catheter ablation vs. lifestyle modification plus antiarrhythmic drugs improved AF freedom at 1 y.
    Ann Intern Med. 2025 Nov 4. doi: 10.7326/ANNALS-25-03844.
    >> Share

  16. ITO K
    In older, frail, VKA-experienced patients with AF, SD-DOACs vs. warfarin reduced thrombotic events without increasing major bleeding.
    Ann Intern Med. 2025;178:JC128.
    >> Share

    September 2025
  17. CENTOR RM, Zimetbaum P
    Annals On Call - Atrial Fibrillation: When Ablation Is the Way to Go.
    Ann Intern Med. 2025 Sep 2:e2503841OC. doi: 10.7326/ANNALS-25-03841.
    >> Share

    August 2025
  18. WEITZ HH, Merli GJ, Lip G
    Web Exclusive. Annals Consult Guys - Anticoagulation, Atrial Fibrillation, and Lower Gastrointestinal Bleeding.
    Ann Intern Med. 2025;178:e2503595CG.
    >> Share

    July 2025

  19. Annals Video Summary - Catheter and Surgical Ablation for Atrial Fibrillation: A Systematic Review and Meta-analysis.
    Ann Intern Med. 2025 Jul 1:e2502118VS. doi: 10.7326/ANNALS-25-02118.
    >> Share

  20. WAKS JW, Zimetbaum P
    The Significant Benefits of Ablation for Rhythm Control of Atrial Fibrillation.
    Ann Intern Med. 2025 Jul 1. doi: 10.7326/ANNALS-25-02222.
    >> Share

  21. MONTANE B, Zhang S, Wolfe JD, Prime S, et al
    Catheter and Surgical Ablation for Atrial Fibrillation : A Systematic Review and Meta-analysis.
    Ann Intern Med. 2025 Jul 1. doi: 10.7326/ANNALS-25-00253.
    >> Share

    June 2025
  22. KATSANOS AH, Douketis JD
    In survivors of ICH with AF, DOACs reduced incident ischemic stroke and increased recurrent ICH at a median 1.4 y.
    Ann Intern Med. 2025 Jun 3. doi: 10.7326/ANNALS-25-01772.
    >> Share

  23. OGUNTALA JO, Yan AT
    In AF with stable CAD, an OAC alone does not increase ischemic events and reduces major bleeding vs. OAC + SAPT at a mean 22 mo.
    Ann Intern Med. 2025;178:JC65.
    >> Share

    May 2025
  24. ALBERTS MJ
    In patients with subclinical AF, apixaban vs. aspirin reduced stroke or systemic embolism at 3.5 y in those with previous stroke or TIA.
    Ann Intern Med. 2025 May 6. doi: 10.7326/ANNALS-25-01330.
    >> Share

  25. MANSOOR H, Elgendy IY
    In AF with recent ACS or PCI, apixaban reduced total bleeding vs. VKA; aspirin increased total bleeding vs. placebo at 6 mo.
    Ann Intern Med. 2025;178:JC57.
    >> Share

  26. KHATTAK S, Al-Ansari A, Alfaraidhy M, Rajah F, et al
    Cardiology: What You May Have Missed in 2024.
    Ann Intern Med. 2025;178.
    >> Share

    April 2025
  27. ABDEL-QADIR H, Gunn M, Fang J, Odugbemi T, et al
    Risk for Stroke After Newly Diagnosed Atrial Fibrillation During Hospitalization for Other Primary Diagnoses : A Retrospective Cohort Study.
    Ann Intern Med. 2025 Apr 22. doi: 10.7326/ANNALS-24-01967.
    >> Share

  28. PATEL NS, Joglar JA
    A New Perspective on Atrial Fibrillation "Provoked" by Hospitalization.
    Ann Intern Med. 2025 Apr 22. doi: 10.7326/ANNALS-25-01073.
    >> Share

    March 2025
  29. LADER EW
    In previous MI with ventricular tachycardia (VT), catheter ablation reduced mortality or VT events more than antiarrhythmic drug therapy at 4 y.
    Ann Intern Med. 2025 Mar 4. doi: 10.7326/ANNALS-25-00336.
    >> Share

    February 2025
  30. SMETANA GW, Gelfand EV, Tung P, Burns RB, et al
    How Would You Manage This Patient With Recent-Onset Atrial Fibrillation? Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
    Ann Intern Med. 2025 Feb 11. doi: 10.7326/ANNALS-24-03490.
    >> Share

  31. SHARMA M, Srivastava A
    In acute ischemic stroke with AF, early DOAC initiation was noninferior to delayed initiation for ischemic and hemorrhagic outcomes at 90 d.
    Ann Intern Med. 2025 Feb 4. doi: 10.7326/ANNALS-24-03879.
    >> Share

    January 2025
  32. BATES ER
    In subclinical AF, apixaban vs. aspirin reduced stroke or systemic embolism at 3.5 y, regardless of duration of recent subclinical AF episodes.
    Ann Intern Med. 2025 Jan 7. doi: 10.7326/ANNALS-24-03370.
    >> Share

    November 2024
  33. ROMITI GF, Talerico G
    In subclinical AF, the benefit of apixaban vs. aspirin on stroke or systemic embolism trended higher with CHA(2)DS(2)-VASc >4.
    Ann Intern Med. 2024;177:JC125.
    >> Share

    July 2024
  34. SIMON TG, Singer DE, Zhang Y, Mastrorilli JM, et al
    Comparative Effectiveness and Safety of Apixaban, Rivaroxaban, and Warfarin in Patients With Cirrhosis and Atrial Fibrillation : A Nationwide Cohort Study.
    Ann Intern Med. 2024 Jul 9. doi: 10.7326/M23-3067.
    >> Share

  35. BARNES GD
    In device-detected AF, DOACs vs. aspirin or placebo reduce ischemic stroke and increase major bleeding.
    Ann Intern Med. 2024 Jul 2. doi: 10.7326/ANNALS-24-00652.
    >> Share

    June 2024
  36. WEITZ HH, Merli GJ, Lip GYH
    Annals Consult Guys - The ABCs of Atrial Fibrillation.
    Ann Intern Med. 2024;177:e2400618CG.
    >> Share

  37. FIELD TS
    In cryptogenic stroke and atrial cardiopathy, apixaban did not reduce recurrent stroke vs. aspirin.
    Ann Intern Med. 2024;177:JC65.
    >> Share

    May 2024
  38. SPOSATO LA, Hill MD
    In AF, CHA(2)DS(2)-VASc 1 subgroups did not differ for predicting risk for arterial thromboembolism at 1 y.
    Ann Intern Med. 2024 May 7. doi: 10.7326/J24-0023.
    >> Share

  39. DUNN A
    In older patients with AF and frailty, switching from VKA to NOAC therapy increased a composite of major or CRNM bleeding at 12 mo.
    Ann Intern Med. 2024;177:JC57.
    >> Share

    March 2024
  40. SHADRIN IY, Newby LK
    In subclinical AF, apixaban reduced stroke or systemic embolism but increased major bleeding vs. aspirin at 3.5 y.
    Ann Intern Med. 2024;177:JC26.
    >> Share

    January 2024
  41. ISHIGUCHI H, Lip GYH
    In symptomatic AF, catheter ablation vs. medical therapy reduced depression and anxiety symptoms at 12 mo.
    Ann Intern Med. 2024 Jan 2. doi: 10.7326/J23-0105.
    >> Share

  42. LOPEZ J, Borzak S
    In noncardiac thoracic surgery, low-dose colchicine did not reduce AF or myocardial injury after noncardiac surgery at 14 d.
    Ann Intern Med. 2024;177:JC3.
    >> Share

    December 2023
  43. BROPHY J
    In symptomatic AF with end-stage HF, adding catheter ablation to medical therapy improved clinical outcomes at 18 mo.
    Ann Intern Med. 2023;176:JC137.
    >> Share

    October 2023
  44. MCINTYRE WF, Vadakken ME, Connolly SJ, Mendoza PA, et al
    Atrial Fibrillation Recurrence in Patients With Transient New-Onset Atrial Fibrillation Detected During Hospitalization for Noncardiac Surgery or Medical Illness : A Matched Cohort Study.
    Ann Intern Med. 2023 Oct 3. doi: 10.7326/M23-1411.
    >> Share

  45. BARNES GD
    In adults, MRAs reduce AF occurrence vs. non-MRAs.
    Ann Intern Med. 2023;176:JC114.
    >> Share

    September 2023
  46. TON IT, Moon J, Sengul A, Mody FV, et al
    Evidence-Based Cardiovascular Disease Medicines' Availability in Low-Cost Generic Drug Programs in the United States : A Cross-Sectional Study.
    Ann Intern Med. 2023 Sep 5. doi: 10.7326/M23-0287.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016